miR-17-92 Cluster Promotes Cholangiocarcinoma Growth
Authors:
Open Access
- 1 October 2014
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 184 (10) , 2828-2839
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DK077776, CA134568, CA102325, CA106280)
This publication has 47 references indexed in Scilit:
- Pathogenesis, Diagnosis, and Management of CholangiocarcinomaGastroenterology, 2013
- MicroRNA-18a Enhances the Interleukin-6-mediated Production of the Acute-phase Proteins Fibrinogen and Haptoglobin in Human HepatocytesJournal of Biological Chemistry, 2011
- Subtle variations in Pten dose determine cancer susceptibilityNature Genetics, 2010
- Intrahepatic Cholangiocarcinoma Progression: Prognostic Factors and Basic MechanismsClinical Gastroenterology and Hepatology, 2009
- Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3–microRNA Cluster 17/92 PathwayCirculation Research, 2009
- The Expression of Phospho-AKT, Phospho-mTOR, and PTEN in Extrahepatic CholangiocarcinomaClinical Cancer Research, 2009
- Human microRNA clusters: Genomic organization and expression profile in leukemia cell linesBiochemical and Biophysical Research Communications, 2006
- Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption ofSmad4 andPten in miceJournal of Clinical Investigation, 2006
- IL-6 activates serum and glucocorticoid kinase via p38α mitogen-activated protein kinase pathwayAmerican Journal of Physiology-Cell Physiology, 2005
- Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancersProceedings of the National Academy of Sciences of the United States of America, 2004